People's Pharmacy, Inc.
Outcome
People's Pharmacy, Inc. agreed to pay all remaining assets (valued at approximately $3.5 million), permanently forfeit its pharmacy license and DEA registration, and close after the DOJ alleged it filled dangerous opioid prescriptions while ignoring red flags for six years, causing overdose deaths and street diversion.
Details
People's Pharmacy, Inc. — Opioid Red Flag Violations Causing Deaths and Diversion (2023)
Outcome: People's Pharmacy, Inc. agreed to pay all remaining assets (approximately $3.5 million), permanently forfeit its pharmacy license and DEA registration, and close after the DOJ alleged it filled dangerous opioid prescriptions while ignoring red flags for six years, causing overdose deaths and street diversion.
People's Pharmacy, Inc. operated a retail pharmacy at a Lakewood, Colorado location under the ownership and pharmacist-in-charge supervision of Mahnaz Abharian. The pharmacy operated from at least January 2014 through July 2020, when it closed.
The United States alleged that between January 2014 and July 2020, People's Pharmacy violated the Controlled Substances Act by unlawfully filling prescriptions despite the presence of clear red flags indicating that the prescriptions were not issued for legitimate medical purposes. The red flags included exceptionally high opioid dosages, dangerous combinations of drugs — particularly opioids combined with benzodiazepines and muscle relaxants — that can depress the central nervous system and the ability to breathe.
The government alleged that these violations resulted in serious harms, including overdose deaths and the unlawful diversion of prescription opioids onto illicit markets. The six-year duration of the conduct and its scope of resulting harm made this one of the most significant independent pharmacy enforcement actions filed in the District of Colorado.
As part of the March 2023 settlement, People's Pharmacy agreed to pay all of its remaining assets as a civil penalty — an amount valued at approximately $3.5 million. Critically, the pharmacy and Abharian also agreed to permanently forgo holding a pharmacy license or DEA registration, barring them from any future participation in controlled substance dispensing. The settlement also resolved individual civil liability against Abharian in her capacity as pharmacist-in-charge.
Primary Source: Colorado Pharmacy and Pharmacist Agree to Resolve Allegations — DOJ Colorado
How Crucible Prevents This
Crucible's prescription red-flag detection controls — including thresholds for morphine milligram equivalents, duplicate therapy, and early refill patterns — would have generated mandatory pharmacist review workflows before dispensing. Crucible's audit trail would have documented each override decision, creating accountability for the six-year pattern of ignoring red flags. Automated reporting controls would have escalated systemic patterns to management and compliance oversight before they reached the scale that triggered federal investigation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works